Calithera Biosciences, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CALA on OTC
Industry
Pharmaceutical Preparations
Location
343 Oyster Point Blvd #200, South San Francisco, California

There are no Buy or Sell transactions made by insiders since 8/16/2023

Calithera Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jonathan G. Drachman Director $77.2K Nov 10, 2021
Francesco Parlati Sr. Vp, Research $54.4K Jan 25, 2022
Susan Molineaux PRESIDENT & CEO, Director $14.6K Jan 23, 2023
Christopher Molineaux Sr. Vp, Development $14.6K Jan 23, 2023
Eric Sjogren Sr. Vp, Drug Discovery $3.27K Jan 23, 2023
Stephanie Wong Chief Financial Officer & Secretary $2.56K Jan 23, 2023
Emil Kuriakose Chief Medical Officer $1.37K Jan 23, 2023
Sumita Ray Svp, General Counsel & Chief Compliance Officer Jan 25, 2022
Keith Orford Director Jun 1, 2022
Takeda Pharmaceutical Co Ltd Former 10% Owner Apr 17, 2023
Ward Wolff Director Jun 1, 2022
Deepika Pakianathan Director Jan 27, 2023
Sunil Agarwal Director Jun 1, 2022
Jean George Director Jun 11, 2021
Suzy Jones Director Jun 1, 2022
J. Scott Garland Director Jun 1, 2022
Blake Wise Director Jun 1, 2022

Recent Insider Transactions by Companies or Individuals for Calithera Biosciences, Inc.

Insider Symbol Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership